← All Startups
GlaiveOptix Seed
Nanotechnology to cure blindness
GlaiveOptix is to provide sight to patients with end stage macular diseases utilizing proprietary nanotechnology.
Location
—
Stage
Seed
Website
glaiveoptix.com
LinkedIn
View profile
Health Care
Founders
W
Wayne Woods, PhD ’03
LinkedIn
Similar Startups
Ceribell Series C
Point-of-care EEG for seizure triage and treatment optimization
Xingjuan Chao, PhD ’05, ,
Freenome
Blood test to detect colorectal cancer
Gabriel Otte ’11, ,
Mira
Hormone monitor and supplements
Sylvia Kang, MBA ’13, ,
Epikast Series B
Engage patients and health providers
Vangelis Vergetis ’01, ,
ModMed
Software for specialty medical practices
Daniel Cane ’98, ,
Moderna
mRNA vaccines
Robert Langer ’70, ,